Yi-Shin Huang Selected Research

Yi-Shin Huang Research Topics

Disease

6	Chemical and Drug Induced Liver Injury 01/2014 - 04/2002
5	Hepatitis 02/2010 - 04/2002
4	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 05/2002
3	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 11/2016 - 02/2010
3	Hepatitis B 07/2016 - 09/2014
3	Liver Diseases (Liver Disease) 07/2011 - 11/2002
2	Infections 01/2022 - 01/2018
2	Jaundice (Icterus) 12/2021 - 11/2002
2	Peptic Ulcer (Peptic Ulcers) 10/2019 - 04/2002
2	Neoplasms (Cancer) 10/2019 - 07/2011
2	Fibrosis (Cirrhosis) 07/2011 - 02/2010
2	Hemorrhage 04/2006 - 04/2002
1	Brain Diseases (Brain Disorder) 12/2021
1	Ascites 12/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2021
1	Sepsis (Septicemia) 12/2021
1	Cicatrix (Scar) 11/2021
1	Chronic Renal Insufficiency 11/2021
1	Latent Tuberculosis 11/2021
1	Hyperbilirubinemia 02/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Gastroesophageal Reflux (GERD) 10/2019
1	Liver Neoplasms (Liver Cancer) 10/2019
1	Tuberculosis (Tuberculoses) 01/2018
1	Chronic Hepatitis C 01/2018
1	Adenocarcinoma 03/2016
1	Alcoholic Fatty Liver 07/2014
1	Onychomycosis (Tinea Unguium) 01/2014
1	Mycoses (Diseases, Fungus) 01/2014
1	Multiple Organ Failure (MODS) 04/2010
1	Heat Stroke (Heatstroke) 04/2010
1	Septic Shock (Toxic Shock Syndrome) 04/2010
1	Azotemia 04/2010
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 02/2010
1	Alcoholic Hepatitis 02/2010
1	Fatigue 02/2006
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2006
1	Cholestasis 12/2002
1	Alcoholism (Alcohol Abuse) 11/2002
1	Nausea 11/2002
1	Asthma (Bronchial Asthma) 11/2002
1	Pseudomyxoma Peritonei 07/2002
1	Liver Failure 05/2002
1	Body Weight (Weight, Body) 05/2002
1	Shock 04/2002
1	Ulcer 04/2002

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 11/2021 - 02/2007
4	EnzymesIBA 01/2021 - 02/2007
4	AcetyltransferasesIBA 03/2016 - 04/2002
3	Isoniazid (Ftivazide)FDA LinkGeneric 11/2021 - 04/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2011
2	BilirubinIBA 12/2021 - 05/2002
2	Antitubercular AgentsIBA 01/2018 - 07/2016
2	superoxide dismutase 2IBA 11/2016 - 07/2014
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 07/2014 - 04/2003
1	Alanine Transaminase (SGPT)IBA 12/2021
1	Alkaline PhosphataseIBA 12/2021
1	HLA-B Antigens (HLA-B)IBA 11/2021
1	Carbamazepine (Tegretol)FDA LinkGeneric 11/2021
1	rifapentine (Priftin)FDA Link 11/2021
1	Allopurinol (Remid)FDA LinkGeneric 11/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Proton Pump InhibitorsIBA 10/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Transaminases (Aminotransferases)IBA 09/2014
1	Antifungal AgentsIBA 01/2014
1	Interleukin-12 (IL 12)IBA 02/2010
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	Oxidoreductases (Dehydrogenase)IBA 07/2007
1	glutathione S-transferase M1IBA 07/2007
1	Superoxide DismutaseIBA 07/2007
1	quinone (benzoquinone)IBA 07/2007
1	NAD (NADH)IBA 07/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2006
1	shosaiko-to (TJ9)IBA 02/2006
1	TeaIBA 02/2006
1	usnic acidIBA 07/2005
1	SteroidsIBA 12/2002
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 11/2002
1	Antinuclear AntibodiesIBA 11/2002
1	zafirlukast (Accolate)FDA LinkGeneric 11/2002
1	AlbuminsIBA 05/2002
1	Lidocaine (Xylocaine)FDA LinkGeneric 05/2002
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2002
1	monoethylglycinexylidide (L 86)IBA 05/2002
1	Epinephrine (Adrenaline)FDA LinkGeneric 04/2002
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2002

Therapy/Procedure

3	Therapeutics 11/2021 - 04/2002
2	Blood Transfusion (Blood Transfusions) 11/2002 - 04/2002
1	Renal Dialysis (Hemodialysis) 04/2010
1	Critical Care (Surgical Intensive Care) 04/2010
1	Drug Therapy (Chemotherapy) 01/2010
1	Ligation 04/2006
1	Tattooing 11/2002
1	Adjuvant Chemotherapy 07/2002